Voclosporin - Qilu Pharmaceutical
Alternative Names: QL-1074; QLG-1074Latest Information Update: 23 May 2024
At a glance
- Originator Qilu Pharmaceutical
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Antivirals; Ciclosporins; Eye disorder therapies; Skin disorder therapies; Small molecules; Urologics; Vascular disorder therapies
- Mechanism of Action Calcineurin inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Lupus nephritis
Most Recent Events
- 25 Dec 2023 Phase-III clinical trials in Lupus nephritis in China (PO) (NCT06406205)